Company: ARMP
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001104659-25-077648
Chunk: 30

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: S-3
Chunk 30
---
;           |

| · | the manner in which the warrant agreements and 
 warrants may be modified; and                  |

| · | any other specific terms, preferences, rights      
 or limitations of or restrictions on the warrants. |

Before exercising their warrants,
holders of warrants will not have any of the rights of holders of common stock or preferred stock purchasable upon such exercise, including
the right to receive dividends, if any, or payments upon our liquidation, dissolution or winding up, or to exercise voting rights.

Exercise of Warrants

Each warrant will entitle
the holder to purchase the number of shares of common stock or preferred stock that we specify in the applicable prospectus supplement
at the exercise price that we describe in the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus
supplement, holders of the warrants may exercise the warrants at any time up to the specified time on the expiration date that we set
forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.

Holders of the warrants may
exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with specified information,
and paying the required amount to the warrant agent in immediately available funds, as provided in the applicable prospectus supplement.
We will set forth on the reverse side of the warrant certificate and in the applicable prospectus supplement the information that the
holder of the warrant will be required to deliver to the warrant agent.

<div align='center'>20</div>

Upon receipt of the required
payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other
office indicated in the applicable prospectus supplement, we will issue and deliver the shares purchasable upon such exercise. If fewer
than all of the warrants represented by the warrant certificate are exercised, then we will issue a new warrant certificate for the remaining
amount of warrants. If we so indicate in the applicable prospectus supplement, holders of the warrants may surrender securities as all
or part of the exercise price for warrants.

Governing Law

Unless we provide otherwise
in the applicable prospectus supplement, the warrants and warrant agreements will be governed by and construed in accordance with the
laws of the State of New York.

Enforceability of Rights by Holders of Warrants

Each warrant agent will act
solely as our agent under the applicable warrant agreement and will not assume any obligation or relationship of agency or trust with
any holder